National Institutes of Health
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
About This Grant
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
Who Can Apply
Focus Areas
Additional Details
- CFDA / ALN Number
- 93.279
- Program Title
- Drug Abuse and Addiction Research Programs
- Source
- Grants.gov · View original listing
Similar Grants
U.S. Mission to Cote d Ivoire
Freedom250 in Côte d’Ivoire American Spaces
$10K – $19KDue June 15, 2026U.S. Mission to Argentina
Grant Administration for Binational Centers (BNCs) in Argentina
$57K – $57KDue June 15, 2026Small Business Administration
Manufacturing in America E2G Grant Initiative
$5M – $5MDue June 15, 2026Center for Medicare and Medicaid Services
Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Up to $3.3MDue in 7 days — May 15, 2026Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Education and Research Centers (T42)
$4.5M – $9MDue October 26, 2028National Institutes of Health
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Due May 8, 2027